An innovation-focused partner bringing branded originator medicines to international markets.
Irifar is a privately held pharmaceutical company based in Ireland, specialising in the in-licensing of innovative, branded originator medicinal products. We are dedicated to expanding patient access to innovative therapies, registering, marketing and promoting them across international markets, working hand in hand with originator partners and a network of established distributors.
01
Who we are
- Legal entity
- Irifar Ltd
- Ownership
- Privately held
- Headquarters
- Dublin, Ireland
- Markets
- Asia, Middle East, Africa, Eastern Europe
- Portfolio
- Innovative branded originator medicines
- Core activity
- In-licensing, registration, marketing & distribution
Bringing a medicine into a new market is never only a commercial exercise, and it is never only a regulatory one. It needs both, working together.
Our model, in brief
We in-license innovative originator products from the companies that develop them, obtain the marketing authorisations and registrations required in each territory, and market and promote the products, delivering them to patients through trusted local distributors.
Our focus is firmly on innovative, branded medicines across specialty and hospital therapeutic areas, where the impact of access to innovation is greatest: pain management, anti-infectives, oncology, haematology, critical care.
We are based in Dublin, Ireland, and we operate across Asia, the Middle East, Africa and Eastern Europe, through established local distributor partners. Operating from Ireland places us inside one of the world's most established pharmaceutical regulatory environments, and gives our partners the assurance that comes with European standards of oversight.
02
Mission and vision
Two statements that decide which products we pursue and which partners we work with.
Mission
To expand access to innovative, branded medicines by in-licensing originator products and registering, marketing and promoting them across international markets.
Vision
To be the trusted international partner of choice for originator companies seeking to bring their innovative medicines to new markets, and for distributors seeking a portfolio of innovative products to represent.
03
Our values
Five commitments that shape how we choose, register and support every product we carry.
-
Patient focus
Everything we do widens access to innovative medicines that change lives.
-
Innovation
We champion branded, originator therapies and the difference they make.
-
Scientific & regulatory excellence
Rigour and precision at every stage.
-
Integrity & compliance
We operate to the highest ethical and regulatory standards.
-
Partnership
We succeed when our originator and distributor partners succeed.
04
Expertise across the full product journey
Our team is drawn from the disciplines that an in-licensing business depends on. Each function is represented in-house rather than outsourced.
In-licensing
Identifying and securing rights to innovative, branded originator products from the companies that develop them, and negotiating the agreements that bring them into our markets.
Regulatory affairs
Preparing and submitting dossiers, managing product registration with national health authorities, and maintaining compliance throughout the product lifecycle.
Marketing and promotion
Building awareness among healthcare professionals and working with local partners to make products available where they are needed.
Supply chain
Managing authenticated supply from originator to market, protecting product integrity, cold chain where required, and continuity of availability.
05
From licence to point of care
Every product we bring to market follows the same stages.
- 01
Identify
We assess unmet need in our markets and identify assets that answer it: innovative, branded products with proven clinical value and an originator able to supply consistently.
- 02
License
We negotiate and structure the licensing agreement, agreeing territory, terms and commercial model with the originator.
- 03
Register
Our regulatory team compiles the dossier and manages submission and approval with the relevant national health authority in each target market.
- 04
Supply
We manage importation and distribution through trusted local partners, keeping the chain of custody authenticated from originator to point of care.
06
Our reach
An Irish base, an international footprint, and a distributor network that carries every product the last mile.
- Headquarters, Ireland
- Our home base and regulatory hub.
- Work Hub, 77 Camden Street Lower
Dublin 2
D02 XE80
Ireland
- International
- Operating across Asia, the Middle East, Africa and Eastern Europe through an established network of local distributor partners.
07
Why authenticity is the whole point
A medicine that is not what it claims to be does not simply fail to help.
Substandard and falsified medicines are a serious and well-documented problem in many parts of the world. A medicine that is not what it claims to be delays effective treatment, erodes trust in healthcare, and in the case of anti-infectives contributes directly to antimicrobial resistance.
This is why our commitment is to authentic, innovative medicines, and why we treat supply chain integrity as a core function rather than a logistics afterthought. We in-license from originators we have assessed, we register products properly with the relevant authorities, and we maintain an authenticated chain of custody through to distribution.
In specialty and hospital care, where our portfolio is concentrated, that assurance is not optional. It is the reason an originator entrusts us with a brand, and the reason a distributor can represent it with confidence.
Talk to us.